(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0^{1,8}]tetradecan-6-yl 2-{[(1R,3S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetate
| Title | Journal |
|---|---|
| Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study. | Journal of drugs in dermatology : JDD 20120701 |
| Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands. | The Journal of antimicrobial chemotherapy 20120501 |
| Interventions for impetigo. | The Cochrane database of systematic reviews 20120118 |
| Design, synthesis, and structure-activity relationship studies of conformationally restricted mutilin 14-carbamates. | Bioorganic & medicinal chemistry letters 20120115 |
| Pleuromutilin and its derivatives-the lead compounds for novel antibiotics. | Mini reviews in medicinal chemistry 20120101 |
| Recent derivatives from smaller classes of fermentation-derived antibacterials. | Expert opinion on therapeutic patents 20120101 |
| Are pleuromutilin antibiotics finally fit for human use? | Annals of the New York Academy of Sciences 20111201 |
| In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20110901 |
| Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. | The Journal of investigative dermatology 20110401 |
| Nonhealing scalp wound infected with Aspergillus niger in an elderly patient. | Cutis 20110401 |
| Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains. | Clinics (Sao Paulo, Brazil) 20110401 |
| Cloning and characterization of an Armillaria gallica cDNA encoding protoilludene synthase, which catalyzes the first committed step in the synthesis of antimicrobial melleolides. | The Journal of biological chemistry 20110304 |
| Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. | BMC microbiology 20110101 |
| Biosensor applications in the field of antibiotic research--a review of recent developments. | Sensors (Basel, Switzerland) 20110101 |
| Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus. | Journal of drugs in dermatology : JDD 20101001 |
| The pleuromutilin antibiotics: a new class for human use. | Current opinion in investigational drugs (London, England : 2000) 20100201 |
| Retapamulin: a novel topical antibiotic. | Indian journal of dermatology, venereology and leprology 20100101 |
| Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis? | Skin therapy letter 20100101 |
| Retapamulin. | British journal of clinical pharmacology 20100101 |
| Retapamulin: an emerging antimicrobial allergen. | Dermatitis : contact, atopic, occupational, drug 20100101 |
| Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens. | Infection and drug resistance 20100101 |
| Mutilins derivatives: from veterinary to human-used antibiotics. | Mini reviews in medicinal chemistry 20091001 |
| Allergic contact cermatitis to retapamulin ointment. | Contact dermatitis 20090801 |
| Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe. | Clinical therapeutics 20090701 |
| Microbiological profile of a new topical antibacterial: retapamulin ointment 1%. | Expert review of anti-infective therapy 20090401 |
| [Pediatric dermatology. New aspects of bacterial skin infections in children]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20090301 |
| Agents for the decolonization of methicillin-resistant Staphylococcus aureus. | Pharmacotherapy 20090301 |
| Topical retapamulin in the management of infected traumatic skin lesions. | Therapeutics and clinical risk management 20090101 |
| Allergic contact dermatitis from retapamulin ointment. | Dermatitis : contact, atopic, occupational, drug 20090101 |
| In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. | The Journal of antimicrobial chemotherapy 20081001 |
| Retapamulin for impetigo and other infections. | Drug and therapeutics bulletin 20081001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080901 |
| Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. | The British journal of dermatology 20080501 |
| A primer on topical antibiotics for the skin and eyes. | Journal of drugs in dermatology : JDD 20080401 |
| Drug treatments for skin disease introduced in 2007. | Skin therapy letter 20080301 |
| Retapamulin (Altabax)--a new topical antibiotic. | The Medical letter on drugs and therapeutics 20080225 |
| Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections. | Drugs of today (Barcelona, Spain : 1998) 20080201 |
| Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? | The Journal of infectious diseases 20080115 |
| Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. | Drugs 20080101 |
| Local antibiotics in dermatology. | Dermatologic therapy 20080101 |
| Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. | American journal of clinical dermatology 20080101 |
| Current and novel antibiotics against resistant Gram-positive bacteria. | Infection and drug resistance 20080101 |
| Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. | Future microbiology 20071201 |
| Altabax approved to treat impetigo. | The Nurse practitioner 20071001 |
| [Introduction to cutaneous bacterial infections]. | Actas dermo-sifiliograficas 20070901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20070601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20070501 |
| In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. | The Journal of antimicrobial chemotherapy 20070401 |
| New drugs: retapamulin, bismuth subcitrate potassium, and rotigotine. | Journal of the American Pharmacists Association : JAPhA 20070101 |
| Altabax (retapamulin ointment), 1%. | Skinmed 20070101 |
| Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. | Dermatology (Basel, Switzerland) 20070101 |
| Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. | Journal of the American Academy of Dermatology 20061201 |
| Molecule of the month. Retapamulin. | Drug news & perspectives 20061201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20061001 |
| Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci. | Antimicrobial agents and chemotherapy 20060701 |
| Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. | Skinmed 20060101 |